Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by Redadmiralon Apr 11, 2018 11:59am
91 Views
Post# 27866898

ACB set to make presentation at BMO cannabis conference

ACB set to make presentation at BMO cannabis conference

09:58 AM EDT, 04/11/2018 (MT Newswires) -- Bank of Montreal (BMO.TO) is pushing deeper into the marijuana sector by assigning an analyst to cover the space and holding its first cannabis conference at the end of May, the Globe & Mail reported.

The bank is filling the role from within, naming Tamy Chen as its cannabis analyst. Since 2015, Chen has been an equity research associate for BMO's consumer products team, working with analyst Peter Sklar.

The two analysts will host BMO's inaugural cannabis conference on May 30 in Toronto. The chief executive officers of Canadian growers Aphria (APH.TO), Aurora Cannabis (ACB.TO), Canopy Growth (WEED.TO), Cronos Group (CRON.V) and MedReleaf (LEAF.TO) are set to make presentations at BMO's conference.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse